Aspeya Denmark A/S

CVR 44838206 · Public limited company (A/S) · Active · Medium risk

Aspeya Denmark A/S is a Public limited company (A/S), founded on , based in Vejle. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.2m and a net result of DKK -14.9m. CEO: Christopher Beck Lambert.

Bankruptcy risk for Aspeya Denmark A/S

1.9%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Company typeA/S · bankruptcy rate 4.4%0.50×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Auditor's statementAudit · bankruptcy rate 5.8%0.66×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44838206
Status
Active
Company type
Public limited company (A/S)
Founded
(2 years)
Address
Dandyvej 19
7100 Vejle
Municipality
Vejle
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 500k
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityNo
Equity ratio31.3%
Current ratio180%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address9
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -5.8mDKK -11.1m
Net profitDKK -14.9mDKK -11.3m
EquityDKK 2.2mDKK -10.9m
Total assetsDKK 7.0mDKK 4.8m
CashDKK 4.0mDKK 1.6m
Short-term debtDKK 3.9mDKK 8.2m
Avg. employees23

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · (venstre underskriver).

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025174
16 May 2024 – 31 Dec 2024176

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChristopher Beck LambertCurrent
CEOJoel Benjamin Rubenstein
BoardChristopher Beck LambertCurrent
BoardMichael Henrik ThomsenCurrent
BoardHelle Egdal NielsenCurrent
Owner (100%)Aspeya Inc.Current
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
FounderAspeya Inc.Current

The CEOs' other companies

Christopher Beck Lambert – 4 other companies

Address history (0 moves)

Dandyvej 19, 7100 Vejle

Former names

Aspeya Denmark A/S – now
Vectura Fertin Pharma Denmark A/S –

Other companies at the same address

Similar companies in Vejle

Questions and answers about Aspeya Denmark A/S

Has Aspeya Denmark A/S gone bankrupt?

No, Aspeya Denmark A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Aspeya Denmark A/S?

Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Aspeya Denmark A/S?

Christopher Beck Lambert is the CEO of Aspeya Denmark A/S.

Who is the auditor of Aspeya Denmark A/S?

Aspeya Denmark A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Aspeya Denmark A/S founded?

Aspeya Denmark A/S was founded on 16 May 2024.

What is the equity of Aspeya Denmark A/S?

Equity was DKK 2.2m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.